Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.

Makan GolizehCarlos E Melendez-PenaBrian J WardSahar SaeedCynthia SantamariaBrian ConwayCurtis CooperMarina B KleinMomar Ndaonull null

Published in: PloS one (2018)

These data suggest that SELDI MS profiling can identify diagnostic serum biomarkers for fibrosis that are both common and distinct in HIV/HCV co-infected and HCV mono-infected individuals.

Keyphrases

hepatitis c virus
human immunodeficiency virus
antiretroviral therapy
hiv positive
hiv infected
hiv testing
multiple sclerosis
mass spectrometry
hiv aids
lymph node
single cell
liver fibrosis